Dyslipidemia-related Risk Factors in Dialysis
Chronic Renal DiseaseCardiovascular Disease1 moreIn this study, we studied lipoprotein abnormalities-related variables as risk factors for the development of cardiovascular disease in patients on renal replacement therapies.We studied 96 dialyzed patients, 62 males and 34 females, on mean age 62.1 years old and 24 healthy controls.We concluded that metabolic acidosis activating the inflammation and lipoprotein oxidation influences the dyslipidemia and cardiovascular morbidity of patients on renal replacement therapies.Dialysis adequacy was positively associated to cardioprotective HDL.Peritoneal dialysis holds a better acidosis level and lower oxidized lipids than hemodialysis modalities.
Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults...
Diabetes MellitusDyslipidemiaThis study is to investigate correlation between Carotid Intima Media Thickness (cIMT) and several factors such as; hs C-reactive protein (CRP), HbA1c, lipid profile in Korean diabetic patients with atherosclerosis. Total 360 patients will be enrolled through 6 sites.
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering...
DyslipidemiaThis is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
DyslipidemiaThe purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.
Additional KIF6 Risk Offers Better Adherence to Statins
Cardiovascular DiseasesDyslipidemiaMany patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.
Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
Type 2 DiabetesThis is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia...
Patients With DyslipidemiaEvaluate the benefit (rate of adherence to the treatment), based on the LDL-C reduction in the group that will be exposed to the program of reinforcement of orientation aimed to the patients, compared to the control group, both in previous use of rosuvastatin.
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
DyslipidemiaThe objective of this proposal is to study the applicability of the hs-CRP assay in the assessment of CV risk in daily clinical conditions where hyperlipidemic population with or without CHD are currently evaluated.
Screening and Management of High-risk Populations of Stroke in Dehui City
Cerebrovascular AccidentStroke3 moreThis epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.
Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control
Cardiovascular DiseasesHyperlipidemiasFimasartan and Rosuvastatin for hypertension and dyslipidemia control